Udit Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Bhopal, Madhya Pradesh, India, established in 2013.
2013 Bhopal, Madhya Pradesh, India Struck Off
Last Updated:
Access Report
About Udit Pharma Private Limited

Udit Pharma Private Limited, a struck off private limited company, was established on 06 February 2013 in Bhopal, Madhya Pradesh, India. Engaging in medical & surgical equipment within the healthcare sector, it holds CIN: U33110MP2013PTC030009. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Yaspal Sinha (Additional Director), Uday Madhav Pishwe (Director). Past directors included Udita Pishwe. Its latest AGM occurred on 16 December 2013, with the balance sheet filed on 31 March 2013. It is based at 59, S.K. Puram Phase-3 Misrod, Bhopal, Madhya Pradesh, 462026.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33110MP2013PTC030009

  • Registration Number

    030009

  • Incorporation Date

    06 February 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 3 Days
  • Last Filing with ROC 31 Mar 2013
Company report

Udit Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Udit Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Udit Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Yaspal Sinha Additional Director 15 Jan 2015 Current
Uday Madhav Pishwe Director 06 Feb 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Jan 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Udit Pharma.

Enhance accessibility to Udit Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Udit Pharma revenue growth over time
Udit Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Udit Pharma?

Unlock access to Udit Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Udit Pharma?

Unlock and access historical data on people associated with Udit Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Udit Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Udit Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Udit Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Yaspal Sinha was appointed as a Additional Director was appointed as a Additional Director on 15 Jan 2015 & has been associated with this company since 11 years 26 days . was documented.

  • Annual General Meeting

    The activity Udit Pharma Private Limited last Annual general meeting of members was held on 16 Dec 2013 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Udit Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Gwalior. was documented.

  • Director Appointment

    The activity Uday Madhav Pishwe was appointed as a Director was appointed as a Director on 06 Feb 2013 & has been associated with this company since 13 years 3 days . was completed.

  • Company Incorporation

    Progress on Udit Pharma Private Limited was registered on 06 Feb 2013 with Roc Gwalior & aged 13 years 3 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Udit Pharma Private Limited?

The CIN of Udit Pharma Private Limited is U33110MP2013PTC030009.

Where is Udit Pharma Private Limited headquartered?

Udit Pharma Private Limited is headquartered at 59, S.K. Puram Phase-3 Misrod, Bhopal, Madhya Pradesh, 462026.

When was Udit Pharma Private Limited incorporated?

Udit Pharma Private Limited was incorporated on 06 February 2013.

Who are the current directors of Udit Pharma Private Limited?

The current directors of Udit Pharma Private Limited are

What is the primary industry of Udit Pharma Private Limited?

The primary industry of Udit Pharma Private Limited is Healthcare.

Is Udit Pharma Private Limited a listed company?

Udit Pharma Private Limited is unlisted.

What is the capital structure of Udit Pharma Private Limited?

The authorized capital of Udit Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available